Gene · 3669
Papers4,236
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 4,236
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Breakthrough infection evokes the nasopharyngeal innate immune responses established by SARS-CoV-2-inactivated vaccine. | Front Immunol | 2023 | 37457721 | PubTator, text mining | PubMed |
| Coexistence of diffuse large B-cell lymphoma, acute myeloid leukemia, and untreated lymphoplasmacytic lymphoma/waldenström macroglobulinemia in a same patient: A case report. | World J Clin Cases | 2023 | 37449216 | PubTator, text mining | PubMed |
| Current Understanding on Why Ovarian Cancer Is Resistant to Immune Checkpoint Inhibitors. | Int J Mol Sci | 2023 | 37446039 | PubTator, text mining | PubMed |
| Microchimerism as Post-Transplant Marker of a Chronic Rejection Process. | Int J Mol Sci | 2023 | 37445781 | PubTator, text mining | PubMed |
| Early Cytomegalovirus Reactivation in Renal Recipients Is Associated with High Levels of B Cell Maturation Antigen Transcript Expression Prior to Transplantation. | Int J Mol Sci | 2023 | 37445668 | PubTator, text mining | PubMed |
| A Novel Method Using Fine Needle Aspiration from Tumor-Draining Lymph Nodes Could Enable the Discovery of New Prognostic Markers in Patients with Cutaneous Squamous Cell Carcinoma. | Cancers (Basel) | 2023 | 37444407 | PubTator, text mining | PubMed |
| An HBV susceptibility variant of KNG1 modulates the therapeutic effects of interferons α and λ1 in HBV infection by promoting MAVS lysosomal degradation. | EBioMedicine | 2023 | 37442062 | PubTator, text mining | PubMed |
| Psoriasis Associated Hub Genes Revealed by Weighted Gene Co-Expression Network Analysis. | Cell J | 2023 | 37434459 | PubTator, text mining | PubMed |
| Deep learning identifies a T-cell exhaustion-dependent transcriptional signature for predicting clinical outcomes and response to immune checkpoint blockade. | Oncogenesis | 2023 | 37433793 | PubTator, text mining | PubMed |
| Atraumatic Splenic Rupture as an Unusual Presentation of Hairy Cell Leukemia: A Case Report. | Cureus | 2023 | 37431331 | PubTator, text mining | PubMed |
| ALK-Positive Anaplastic Large Cell Lymphoma Associated With Hemophagocytic Lymphohistiocytosis. | Cureus | 2023 | 37426397 | PubTator, text mining | PubMed |
| Advanced methods and novel biomarkers in autoimmune diseases ‑ a review of the recent years progress in systemic lupus erythematosus. | Front Med (Lausanne) | 2023 | 37425332 | PubTator, text mining | PubMed |
| Immune response and treatment targets of chronic hepatitis B virus infection: innate and adaptive immunity. | Front Cell Infect Microbiol | 2023 | 37424786 | PubTator, text mining | PubMed |
| Structured diagnostic scheme clinical experience sharing: a prospective study of 320 cases of fever of unknown origin in a tertiary hospital in North China. | BMC Infect Dis | 2023 | 37420165 | PubTator, text mining | PubMed |
| Targeting Type I Interferon Induction and Signaling: How Zika Virus Escapes from Host Innate Immunity. | Int J Biol Sci | 2023 | 37416780 | PubTator, text mining | PubMed |
| Gene expression of peripheral blood mononuclear cells and CD8+ T cells from gilts after PRRSV infection. | Front Immunol | 2023 | 37409113 | PubTator, text mining | PubMed |
| Transcriptome-Powered Pluripotent Stem Cell Differentiation for Regenerative Medicine. | Cells | 2023 | 37408278 | PubTator, text mining | PubMed |
| Transcriptional signatures associated with persisting CD19 CAR-T cells in children with leukemia. | Nat Med | 2023 | 37407840 | PubTator, text mining | PubMed |
| Immunity following SARS-CoV-2 vaccination in autoimmune neurological disorders treated with rituximab or ocrelizumab. | Front Immunol | 2023 | 37398654 | PubTator, text mining | PubMed |
| Hairy Cell Leukemia: Hepatic Affinity Status Post Splenectomy. | Cureus | 2023 | 37397667 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3669/papers?page=24